2024-11-20 23:29:22
At the 2022 AAD Annual Meeting, Senhwa Presents Positive Initial Data from Clinical Trial of Silmitasertib Used to Treat Patients with Advanced Basal Cell Carcinoma
Corporate/ 2023-07-24
At the 2022 AAD Annual Meeting, Senhwa P...

Early results showed 2 laBCC (locally advanced Basal Cell Carcinoma) subjects out of 10 experienced a Partial Response (30% decrease in tumo...

Tigermed Reports Strong 2021 Full-Year Results
Corporate/ 2023-07-24
Tigermed Reports Strong 2021 Full-Year R...

HANGZHOU,China,March 28,2022-- Hangzhou Tigermed Consulting Co.,Ltd. ("Tigermed" or the "company") (Stock code: 300347.S...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release